Evidence map›Paper›PMID 36017498›Full record

ArticleFrontiers in genetics2022

Promoter Methylation of

Lei Zhang, Dapeng Li, Lijing Gao, Jinming Fu, Simin Sun, Hao Huang, Ding Zhang, Chenyang Jia, Ting Zheng, Binbin Cui and 2 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Lei ZhangDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Dapeng LiDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Lijing GaoDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Jinming FuDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Simin SunDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Hao HuangDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Ding ZhangDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Chenyang JiaDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Ting ZhengDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Binbin CuiDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China.
Yanlong LiuDepartment of Colorectal Surgery, Harbin Medical University Cancer Hospital, Harbin Medical University, Harbin, China.
Yashuang ZhaoDepartment of Epidemiology, College of Public Health, Harbin Medical University, Harbin, China.
Harbin Medical University · CNThird Affiliated Hospital of Harbin Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early and specific detection of cancer provides an opportunity for appropriate treatment. Although studies have suggested that

Indexed as

biomarkercolorectal cancerdiagnosticDNA methylationQKI

Identifiers

PMID36017498
PMCPMC9395658
OpenAlexW4290729916

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.